Atishay Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 10:21 am

Competitors of Atishay Ltd

All Competitor Stocks of Atishay Ltd

Quarterly Result

Last Updated: July 16, 2025, 12:58 pm

Below is a detailed analysis of the quarterly data for Atishay Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 12.20 Cr.. The value appears to be declining and may need further review. It has decreased from 12.84 Cr. (Mar 2025) to 12.20 Cr., marking a decrease of 0.64 Cr..
• For Expenses, as of Jun 2025, the value is 10.19 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9.89 Cr. (Mar 2025) to 10.19 Cr., marking an increase of 0.30 Cr..
• For Operating Profit, as of Jun 2025, the value is 2.01 Cr.. The value appears to be declining and may need further review. It has decreased from 2.95 Cr. (Mar 2025) to 2.01 Cr., marking a decrease of 0.94 Cr..
• For OPM %, as of Jun 2025, the value is 16.48%. The value appears to be declining and may need further review. It has decreased from 22.98% (Mar 2025) to 16.48%, marking a decrease of 6.50%.
• For Other Income, as of Jun 2025, the value is 0.82 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Mar 2025) to 0.82 Cr., marking an increase of 0.23 Cr..
• For Interest, as of Jun 2025, the value is 0.07 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.11 Cr. (Mar 2025) to 0.07 Cr., marking a decrease of 0.04 Cr..
• For Depreciation, as of Jun 2025, the value is 0.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.36 Cr. (Mar 2025) to 0.47 Cr., marking an increase of 0.11 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.29 Cr.. The value appears to be declining and may need further review. It has decreased from 3.07 Cr. (Mar 2025) to 2.29 Cr., marking a decrease of 0.78 Cr..
• For Tax %, as of Jun 2025, the value is 27.95%. The value appears to be increasing, which may not be favorable. It has increased from 23.13% (Mar 2025) to 27.95%, marking an increase of 4.82%.
• For Net Profit, as of Jun 2025, the value is 1.65 Cr.. The value appears to be declining and may need further review. It has decreased from 2.36 Cr. (Mar 2025) to 1.65 Cr., marking a decrease of 0.71 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.50. The value appears to be declining and may need further review. It has decreased from 2.15 (Mar 2025) to 1.50, marking a decrease of 0.65.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 3:52 am

Growth

Last Updated: September 5, 2025, 2:31 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Atishay Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.38. This value is within the healthy range. It has increased from 5.06 (Mar 24) to 6.38, marking an increase of 1.32.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.31. This value is within the healthy range. It has increased from 4.99 (Mar 24) to 6.31, marking an increase of 1.32.
• For Cash EPS (Rs.), as of Mar 25, the value is 8.04. This value is within the healthy range. It has increased from 6.59 (Mar 24) to 8.04, marking an increase of 1.45.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.26. It has increased from 38.59 (Mar 24) to 44.26, marking an increase of 5.67.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 44.26. It has increased from 38.59 (Mar 24) to 44.26, marking an increase of 5.67.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.58. It has increased from 39.39 (Mar 24) to 46.58, marking an increase of 7.19.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 10.64. This value is within the healthy range. It has increased from 8.77 (Mar 24) to 10.64, marking an increase of 1.87.
• For PBIT / Share (Rs.), as of Mar 25, the value is 8.97. This value is within the healthy range. It has increased from 7.23 (Mar 24) to 8.97, marking an increase of 1.74.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.72. This value is within the healthy range. It has increased from 6.94 (Mar 24) to 8.72, marking an increase of 1.78.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.38. This value is within the healthy range. It has increased from 5.06 (Mar 24) to 6.38, marking an increase of 1.32.
• For PBDIT Margin (%), as of Mar 25, the value is 22.84. This value is within the healthy range. It has increased from 22.25 (Mar 24) to 22.84, marking an increase of 0.59.
• For PBIT Margin (%), as of Mar 25, the value is 19.27. This value is within the healthy range. It has increased from 18.36 (Mar 24) to 19.27, marking an increase of 0.91.
• For PBT Margin (%), as of Mar 25, the value is 18.72. This value is within the healthy range. It has increased from 17.62 (Mar 24) to 18.72, marking an increase of 1.10.
• For Net Profit Margin (%), as of Mar 25, the value is 13.69. This value exceeds the healthy maximum of 10. It has increased from 12.83 (Mar 24) to 13.69, marking an increase of 0.86.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.41. This value is below the healthy minimum of 15. It has increased from 13.10 (Mar 24) to 14.41, marking an increase of 1.31.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.79. This value is within the healthy range. It has increased from 18.39 (Mar 24) to 19.79, marking an increase of 1.40.
• For Return On Assets (%), as of Mar 25, the value is 11.99. This value is within the healthy range. It has increased from 11.50 (Mar 24) to 11.99, marking an increase of 0.49.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.07. This value is within the healthy range. It has increased from 0.02 (Mar 24) to 0.07, marking an increase of 0.05.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.95. It has decreased from 0.96 (Mar 24) to 0.95, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 2.64. This value is within the healthy range. It has decreased from 2.74 (Mar 24) to 2.64, marking a decrease of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 2.62. This value exceeds the healthy maximum of 2. It has increased from 2.53 (Mar 24) to 2.62, marking an increase of 0.09.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 15.67. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 15.67, marking an increase of 15.67.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.42. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 12.42, marking an increase of 12.42.
• For Earning Retention Ratio (%), as of Mar 25, the value is 84.33. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.33, marking an increase of 84.33.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.58. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 87.58, marking an increase of 87.58.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 42.08. This value is within the healthy range. It has increased from 30.09 (Mar 24) to 42.08, marking an increase of 11.99.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 26.23. This value is within the healthy range. It has increased from 18.36 (Mar 24) to 26.23, marking an increase of 7.87.
• For Enterprise Value (Cr.), as of Mar 25, the value is 217.38. It has increased from 77.86 (Mar 24) to 217.38, marking an increase of 139.52.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.25. This value exceeds the healthy maximum of 3. It has increased from 1.80 (Mar 24) to 4.25, marking an increase of 2.45.
• For EV / EBITDA (X), as of Mar 25, the value is 18.60. This value exceeds the healthy maximum of 15. It has increased from 8.09 (Mar 24) to 18.60, marking an increase of 10.51.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has increased from 1.85 (Mar 24) to 4.31, marking an increase of 2.46.
• For Retention Ratios (%), as of Mar 25, the value is 84.32. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.32, marking an increase of 84.32.
• For Price / BV (X), as of Mar 25, the value is 4.54. This value exceeds the healthy maximum of 3. It has increased from 1.89 (Mar 24) to 4.54, marking an increase of 2.65.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.31. This value exceeds the healthy maximum of 3. It has increased from 1.85 (Mar 24) to 4.31, marking an increase of 2.46.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness